Dr. Katherine Lynne Werbaneth, MD

Dr. Werbaneth practices at Sutter Medical Center, Sacramento in Sacramento, California, part of Sutter Health.

Dr. Werbaneth's NPI, 1871980839, was assigned on April 16, 2015. Dr. Werbaneth graduated from Boston University School Of Medicine in 2015. Dr. Werbaneth holds California license 1195080.

Dr. Werbaneth's primary practice is Sutter Medical Center, Sacramento, at 2825 Capitol Avenue, Sacramento, CA 95816 in Sacramento County. The practice phone is (916) 454-2222.

Dr. Werbaneth's primary practice is Sutter Medical Center, Sacramento in Sacramento, California, part of Sutter Health. Dr. Werbaneth is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Werbaneth to 4 more hospitals, 1 community health center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Werbaneth practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Werbaneth's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Werbaneth is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dr. Werbaneth is licensed in California.

Dmand AI lists epilepsy among the conditions Dr. Werbaneth treats.

CMS data shows 408 Medicare services from Dr. Werbaneth across 8 procedure codes in 2024, for 239 Medicare patients. Medicare paid $47,418 for them.

CMS counts 239 Medicare patients who saw Dr. Werbaneth in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Werbaneth's median patient age at 57, with 53% women.

In 2024, Dr. Werbaneth wrote 1,506 Medicare Part D claims for 205 patients. 83% of them were for generic drugs. CMS names the drug for 1,390 of them, across 25 drugs with 11 or more claims each, at $705,701 in total drug cost. In 2023, CMS named 1,234 claims across 24 drugs.

CMS lists Dr. Werbaneth as offering telehealth.

Dmand AI links 14 papers to Dr. Werbaneth, published from 2014 to 2023. 2020 was the busiest year, with 4. The most frequent topics are Seizures, Electroencephalography and Epilepsy. Dr. Werbaneth has published most often in Neurohospitalist. Dr. Werbaneth's most frequent co-authors are Robert Scott Fisher, MD, Kimford Jay Meador, MD and Brian Jeffery Scott, MD.

CMS Open Payments shows 96 general payments to Dr. Werbaneth from 10 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 71% of the total. Ceribell, Inc. paid the most, $64,884.

Dmand AI lists 2 awards for Dr. Werbaneth, most recently Neurology Resident Teaching Award in 2019.

Dr. Werbaneth graduated from Boston University School Of Medicine in 2015.

Dr. Werbaneth is in network with 12 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.